Celldex Therapeutics, Inc. - COM NEW (CLDX)

Q3 2021 13F Holders as of 9/30/2021

Type / Class
Equity / COM NEW
Number of holders
157
Total Shares
43.2M
Shares change
+7.59M
Total reported value, excl. options
$2.33B
Value change
+$430M
Put/Call ratio
0.69
Number of buys
92
Number of sells
-61
Price
$53.99
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.